Connection
Lisa Bero to World Health Organization
This is a "connection" page, showing publications Lisa Bero has written about World Health Organization.
|
|
Connection Strength |
|
|
|
|
|
4.912 |
|
|
|
-
Wang Z, Grundy Q, Parker L, Bero L. Variations in processes for guideline adaptation: a qualitative study of World Health Organization staff experiences in implementing guidelines. BMC Public Health. 2020 Nov 23; 20(1):1758.
Score: 0.741
-
Wang Z, Grundy Q, Parker L, Bero L. Health promoter, advocate, legitimiser - the many roles of WHO guidelines: a qualitative study. Health Res Policy Syst. 2019 Dec 05; 17(1):96.
Score: 0.693
-
Wang Z, Norris SL, Bero L. Implementation plans included in World Health Organisation guidelines. Implement Sci. 2016 05 20; 11(1):76.
Score: 0.542
-
Magrini N, Robertson J, de Joncheere K, Bero L. On WHO's essential medicines process and transparency. BMJ. 2014 Sep 17; 349:g5637.
Score: 0.483
-
Bero LA, Ghersi D. Making systematic reviews global. Cochrane Database Syst Rev. 2011 Feb 16; (8):ED000020.
Score: 0.377
-
Bero L, Carson B, Moller H, Hill S. To give is better than to receive: compliance with WHO guidelines for drug donations during 2000-2008. Bull World Health Organ. 2010 Dec 01; 88(12):922-9.
Score: 0.365
-
McDonald S, Fabbri A, Parker L, Williams J, Bero L. Medical donations are not always free: an assessment of compliance of medicine and medical device donations with World Health Organization guidelines (2009-2017). Int Health. 2019 09 02; 11(5):379-402.
Score: 0.170
-
Parker L, Williams J, Bero L. Ethical drug marketing criteria for the 21st century. BMJ. 2018 Apr 30; 361:k1809.
Score: 0.155
-
Mahmic-Kaknjo M, Jelicic-Kadic A, Utrobicic A, Chan K, Bero L, Maru?ic A. Essential medicines availability is still suboptimal in many countries: a scoping review. J Clin Epidemiol. 2018 06; 98:41-52.
Score: 0.153
-
Alexander PE, Gionfriddo MR, Li SA, Bero L, Stoltzfus RJ, Neumann I, Brito JP, Djulbegovic B, Montori VM, Norris SL, Sch?nemann HJ, Thabane L, Guyatt GH. A number of factors explain why WHO guideline developers make strong recommendations inconsistent with GRADE guidance. J Clin Epidemiol. 2016 Feb; 70:111-22.
Score: 0.129
-
Alexander PE, Brito JP, Neumann I, Gionfriddo MR, Bero L, Djulbegovic B, Stoltzfus R, Montori VM, Norris SL, Sch?nemann HJ, Guyatt GH. World Health Organization strong recommendations based on low-quality evidence (study quality) are frequent and often inconsistent with GRADE guidance. J Clin Epidemiol. 2016 Apr; 72:98-106.
Score: 0.123
-
Alexander PE, Bero L, Montori VM, Brito JP, Stoltzfus R, Djulbegovic B, Neumann I, Rave S, Guyatt G. World Health Organization recommendations are often strong based on low confidence in effect estimates. J Clin Epidemiol. 2014 Jun; 67(6):629-34.
Score: 0.115
-
Bero LA, Hill S, Habicht J, Mathiesen M, Starkopf J. The updated clinical guideline development process in Estonia is an efficient method for developing evidence-based guidelines. J Clin Epidemiol. 2013 Feb; 66(2):132-9.
Score: 0.105
-
Bero LA, Binder L. The Cochrane Collaboration review prioritization projects show that a variety of approaches successfully identify high-priority topics. J Clin Epidemiol. 2013 May; 66(5):472-3.
Score: 0.105
-
Anson A, Ramay B, de Esparza AR, Bero L. Availability, prices and affordability of the World Health Organization's essential medicines for children in Guatemala. Global Health. 2012 Jul 02; 8:22.
Score: 0.104
-
Hill S, Yang A, Bero L. Priority medicines for maternal and child health: a global survey of national essential medicines lists. PLoS One. 2012; 7(5):e38055.
Score: 0.103
-
Krle?a-Jeri? K, Lemmens T, Reveiz L, Cuervo LG, Bero LA. Prospective registration and results disclosure of clinical trials in the Americas: a roadmap toward transparency. Rev Panam Salud Publica. 2011 Jul; 30(1):87-96.
Score: 0.097
-
Millar TP, Wong S, Odierna DH, Bero LA. Applying the essential medicines concept to US preferred drug lists. Am J Public Health. 2011 Aug; 101(8):1444-8.
Score: 0.096
-
Montini T, George A, Martin-Mollard M, Bero LA. The role of public participation in public health initiatives: an analysis of the WHO Framework Convention on Tobacco Control. Glob Public Health. 2010; 5(1):48-61.
Score: 0.087
-
Pega F, Momen NC, Gagliardi D, Bero LA, Boccuni F, Chartres N, Descatha A, Dzhambov AM, Godderis L, Loney T, Mandrioli D, Modenese A, van der Molen HF, Morgan RL, Neupane S, Pachito D, Paulo MS, Prakash KC, Scheepers PTJ, Teixeira L, Tenkate T, Woodruff TJ, Norris SL. Assessing the quality of evidence in studies estimating prevalence of exposure to occupational risk factors: The QoE-SPEO approach applied in the systematic reviews from the WHO/ILO Joint Estimates of the Work-related burden of disease and Injury. Environ Int. 2022 03; 161:107136.
Score: 0.050
-
Pega F, Norris SL, Backes C, Bero LA, Descatha A, Gagliardi D, Godderis L, Loney T, Modenese A, Morgan RL, Pachito D, Paulo MBS, Scheepers PTJ, Schl?nssen V, Sgargi D, Silbergeld EK, S?rensen K, Sutton P, Tenkate T, Torre?o Corr?a da Silva D, Ujita Y, van Deventer E, Woodruff TJ, Mandrioli D. RoB-SPEO: A tool for assessing risk of bias in studies estimating the prevalence of exposure to occupational risk factors from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury. Environ Int. 2020 02; 135:105039.
Score: 0.043
-
Chartres N, Bero LA, Norris SL. A review of methods used for hazard identification and risk assessment of environmental hazards. Environ Int. 2019 02; 123:231-239.
Score: 0.040
-
Lawrence M, Naude C, Armstrong R, Bero L, Covic N, Durao S, Ghersi D, Macdonald G, MacLehose H, Margetts B, Tovey D, Volmink J, Young T. A call to action to reshape evidence synthesis and use for nutrition policy. Cochrane Database Syst Rev. 2016 Nov 21; 11:ED000118.
Score: 0.035
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|